Myeloma
Results
Phase 1
This study looked at Reolysin with other treatment for people whose myeloma had come back or treatment had stopped working.
The study was open for people to join in 2017 and 2018. The team reported the results in 2022.
Recruitment start: 1 February 2017
Recruitment end: 1 November 2018
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Gordon Cook
Myeloma UK
University of Leeds
Oncolytics Biotech Inc.
Celgene
Last reviewed: 12 December 2024
CRUK internal database number: 14831
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
